Fulcrum Equity Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
N
Fulcrum Equity Management's DXCM Position: Q1 2022 in Review
Fulcrum Equity Management sold out of DexCom (DXCM) in Q1 2022, closing a stake of 1,904 shares — an estimated $256K sold.
Fulcrum Equity Management first reported a position in DXCM in Q3 2021 and held it in 2 quarters. The position peaked at $267K in Q3 2021. 861 funds tracked by Wall St. Rank hold DXCM as of Q1 2022.
- Fulcrum Equity Management reported no remaining DexCom position as of Q1 2022 after selling out during the quarter.
- Fulcrum Equity Management sold 1,904 DexCom shares in Q1 2022, an estimated $256K.
- Fulcrum Equity Management first reported a position in DexCom in Q3 2021 and held it in 2 quarters.
- Fulcrum Equity Management's DexCom position peaked at $267K in Q3 2021.
- 861 funds tracked by Wall St. Rank held DexCom as of Q1 2022.
Based on Fulcrum Equity Management's 13F filing for Q1 2022, filed 15 Apr 2022.